van Cruijsen, Hester <br/><br/>
Sunitinib-induced myeloid lineage redistribution in renal cell cancer patients: CD1c+ dendritic cell frequency predicts progression-free survival.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Sep 2008 
 - 5884-92 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1078-0432 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-08-0656  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antigens, CD1--metabolism<br/>Carcinoma, Renal Cell--drug therapy<br/>Cell Lineage<br/>Dendritic Cells--immunology<br/>Disease-Free Survival<br/>Female<br/>Glycoproteins--metabolism<br/>Humans<br/>Indoles--pharmacology<br/>Kidney Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Myeloid Cells--immunology<br/>Pyrroles--pharmacology<br/>Sunitinib